In preliminary experiments conducted on immortalized myoblasts derived from DM1 patients (172), the results showed that Cas13-mediated DMPK knockdown effectively reduced MBNL nuclear foci and corrected splicing defects. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.